172 related articles for article (PubMed ID: 8658631)
1. Preexisting antibodies: the clinical relevance of auto-B-lymphocyte antibody and positive B-cell crossmatch.
Mongkolsuk T; Chiewsilp P; Sujirachato K; Sumethkul V; Jirasiritham S; Chalermsanyakorn P; Danviriyasup K
Transplant Proc; 1996 Jun; 28(3):1215-6. PubMed ID: 8658631
[No Abstract] [Full Text] [Related]
2. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of a positive B-cell crossmatch on renal transplantation: a multi-transplant center evaluation.
Bryan CF; Aeder MI; Helling TS; Luger AM; Nelson PW; Pierce GE
Transplant Proc; 1993 Feb; 25(1 Pt 1):247-50. PubMed ID: 8438288
[No Abstract] [Full Text] [Related]
4. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.
Akalin E; Ames S; Sehgal V; Fotino M; Daly L; Murphy B; Bromberg JS
Transplantation; 2003 Nov; 76(10):1444-7. PubMed ID: 14657683
[TBL] [Abstract][Full Text] [Related]
5. Donor-specific flow cytometric cross-match after kidney transplantation.
Puig N; Pallardó LM; Villalba JV; Sánchez J; Crespo J; Rodriguez R; Montoro JA
Transplant Proc; 1995 Aug; 27(4):2369-70. PubMed ID: 7652842
[No Abstract] [Full Text] [Related]
6. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection.
Mattsson J; Nordlander A; Remberger M; Uhlin M; Holgersson J; Ringdén O; Hauzenberger D
Bone Marrow Transplant; 2010 Feb; 45(2):235-8. PubMed ID: 19561647
[TBL] [Abstract][Full Text] [Related]
8. Renal graft survival is not influenced by a positive flow B-cell crossmatch.
Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D
Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594
[TBL] [Abstract][Full Text] [Related]
9. Differential crossmatch in renal transplantation: allopositive historical crossmatch (B and/or T) but current T-cell negative crossmatch.
Guerin C; Pomier G; Fleuru H; Laverne S; Le Petit JC; Berthoux FC
Transplant Proc; 1990 Oct; 22(5):2286. PubMed ID: 2219371
[No Abstract] [Full Text] [Related]
10. The clinical importance of flow cytometry crossmatch in the context of CDC crossmatch results.
Graff RJ; Buchanan PM; Dzebisashvili N; Schnitzler MA; Tuttle-Newhall J; Xiao H; Schadde E; Gheorghian A; Lentine KL
Transplant Proc; 2010 Nov; 42(9):3471-4. PubMed ID: 21094799
[TBL] [Abstract][Full Text] [Related]
11. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
Creemers P; Brink J; Kahn D
Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
Billen EV; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
[TBL] [Abstract][Full Text] [Related]
13. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
14. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
[TBL] [Abstract][Full Text] [Related]
15. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch.
Limaye S; O'Kelly P; Harmon G; O'Neill D; Dorman AM; Walshe J; Donohoe J; Little D; Conlon PJ; Keogan MT
Transplantation; 2009 Apr; 87(7):1052-6. PubMed ID: 19352127
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte crossmatching in the sensitized patient.
Chiewsilp P; Mongkolsuk T; Mavichak V; Buabut B; Sujirachato K; Jirasiritham S; Boonpucknavig V
Transplant Proc; 1996 Jun; 28(3):1267. PubMed ID: 8658653
[No Abstract] [Full Text] [Related]
17. Clinical relevance of pretransplant flow cytometric crossmatches with T and B lymphocytes in kidney transplantation.
Berteli AJ; Daniel V; Pomer S; Opelz G
Transplant Proc; 1990 Aug; 22(4):1895-6. PubMed ID: 2389477
[No Abstract] [Full Text] [Related]
18. Renal transplantation with B cell-positive crossmatch.
Mishra MN; Saxena VK
Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1077-9. PubMed ID: 22982930
[No Abstract] [Full Text] [Related]
19. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study.
Opelz G; Döhler B; Süsal C
Hum Immunol; 2009 Aug; 70(8):627-30. PubMed ID: 19375469
[TBL] [Abstract][Full Text] [Related]
20. Renal allograft survival in CSA-treated patients with positive donor-specific B cell crossmatches.
Noreen HJ; van der Hagen E; Bach FH; Najarian JS; Fryd DS
Transplant Proc; 1989 Feb; 21(1 Pt 1):691-2. PubMed ID: 2650224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
